Talazoparib plus enzalutamide improved rPFS for patients with androgen pathway modulation‐sensitive prostate cancer
Year: 2026
Type: article
Source: Cancer
DOI: 10.1002/cncr.70589
Author: Leah Lawrence
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7222871740